Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 3, 2015, 67 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $604.38 to $199,999,963.35.

Highlighted Stocks Traded by Insiders:

SolarCity (SCTY) - FREE Research Report

Weissman Seth R, who is EVP, General Counsel at SolarCity, sold 26,463 shares at $51.75 on Feb. 3, 2015. Following this transaction, the EVP, General Counsel owned 105,851 shares meaning that the stake was reduced by 20% with the 26,463-share transaction.

The shares most recently traded at $54.55, up $2.80, or 5.12% since the insider transaction. Historical insider transactions for SolarCity go as follows:

  • 4-Week # shares bought: 107,434
  • 4-Week # shares sold: 26,463
  • 12-Week # shares bought: 107,434
  • 12-Week # shares sold: 113,963
  • 24-Week # shares bought: 107,434
  • 24-Week # shares sold: 327,366

The average volume for SolarCity has been 2.4 million shares per day over the past 30 days. SolarCity has a market cap of $5.1 billion and is part of the technology sector and electronics industry. Shares are up 1.48% year-to-date as of the close of trading on Tuesday.

SolarCity Corporation designs, installs, and sells or leases solar energy systems to residential and commercial customers, and government entities in the United States. Currently, there are 6 analysts who rate SolarCity a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCTY - FREE

TheStreet Quant Ratings rates SolarCity as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, generally high debt management risk, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full SolarCity Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

First Business Financial Services (FBIZ) - FREE Research Report

Voeks Dean W, who is Director at First Business Financial Services, bought 14 shares at $43.17 on Feb. 3, 2015. Following this transaction, the Director owned 5,546 shares meaning that the stake was boosted by 0.25% with the 14-share transaction.

The shares most recently traded at $44.55, up $1.38, or 3.1% since the insider transaction. Historical insider transactions for First Business Financial Services go as follows:

  • 4-Week # shares bought: 80
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 80
  • 12-Week # shares sold: 1,500
  • 24-Week # shares bought: 80
  • 24-Week # shares sold: 1,500

The average volume for First Business Financial Services has been 11,800 shares per day over the past 30 days. First Business Financial Services has a market cap of $170.2 million and is part of the financial sector and banking industry. Shares are down 10.6% year-to-date as of the close of trading on Tuesday.

First Business Financial Services, Inc. The stock currently has a dividend yield of 1.96%. The company has a P/E ratio of 12.0. Currently, there are 4 analysts who rate First Business Financial Services a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FBIZ - FREE

TheStreet Quant Ratings rates First Business Financial Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full First Business Financial Services Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cardiovascular Systems (CSII) - FREE Research Report

Betterley Laurence L, who is Chief Financial Officer at Cardiovascular Systems, sold 10,825 shares at $35.25 on Feb. 3, 2015. Following this transaction, the Chief Financial Officer owned 183,711 shares meaning that the stake was reduced by 5.56% with the 10,825-share transaction.

The shares most recently traded at $34.90, down $0.35, or 0.99% since the insider transaction. Historical insider transactions for Cardiovascular Systems go as follows:

  • 4-Week # shares sold: 4,212
  • 12-Week # shares sold: 10,897
  • 24-Week # shares bought: 10,250
  • 24-Week # shares sold: 65,494

The average volume for Cardiovascular Systems has been 227,700 shares per day over the past 30 days. Cardiovascular Systems has a market cap of $1.1 billion and is part of the health care sector and health services industry. Shares are up 13.56% year-to-date as of the close of trading on Tuesday.

Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. Currently, there are 7 analysts who rate Cardiovascular Systems a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSII - FREE

TheStreet Quant Ratings rates Cardiovascular Systems as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Get the full Cardiovascular Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null